Abstract:The study results suggest QIO activities can improve outpatient diabetes care; however, limitations in the study design preclude any definitive remarks.
“…A performance rate of 97.0% for at least one HbA1c test was high compared with a rate of 70–91% described in recent US studies using administrative data [5–11] and the National Committee for Quality Assurance (NCQA) report [2], and compared with 92–97% found in population‐based studies in the UK [3,12,19]. Our results, however, could be overestimated as the patients were limited to those who received medical care every month during the study period.…”
Section: Discussioncontrasting
confidence: 64%
“…We selected three process indicators for quality of diabetes care: (1) frequency of haemoglobin A1c (HbA1c) testing; (2) annual eye examination rate; and (3) annual nephropathy screening rate, based on the recommendations of JDS [13] and American Diabetes Association (ADA) standards [1] that were valid as of May 2006. A number of previous studies have accepted the frequency of HbA1c testing as a process indicator for blood glucose control [3–12], although the JDS guidelines do not state the recommended frequency of HbA1c testing. Hence, we defined ‘≥4 HbA1c testing during the study period’ as an indicator of good performance, based on the ADA recommendation of HbA1c testing every 3 months for unstable patients [1].…”
Section: Methodsmentioning
confidence: 99%
“…Several studies have assessed the quality of diabetes care by using administrative data in the USA [5–11] and other developed countries [3,12] in an effort to improve diabetes care practices. However, although the Japan Diabetes Society (JDS) issued its comprehensive practice guidelines in 2004 [13], to date, very few studies examining the quality of diabetes care have been published [14–16].…”
We found high performance rates for HbA1c testing, while the annual rates for eye examinations and nephropathy screenings were suboptimal. Using administrative data would facilitate more comprehensive assessment of the quality of care in Japan.
“…A performance rate of 97.0% for at least one HbA1c test was high compared with a rate of 70–91% described in recent US studies using administrative data [5–11] and the National Committee for Quality Assurance (NCQA) report [2], and compared with 92–97% found in population‐based studies in the UK [3,12,19]. Our results, however, could be overestimated as the patients were limited to those who received medical care every month during the study period.…”
Section: Discussioncontrasting
confidence: 64%
“…We selected three process indicators for quality of diabetes care: (1) frequency of haemoglobin A1c (HbA1c) testing; (2) annual eye examination rate; and (3) annual nephropathy screening rate, based on the recommendations of JDS [13] and American Diabetes Association (ADA) standards [1] that were valid as of May 2006. A number of previous studies have accepted the frequency of HbA1c testing as a process indicator for blood glucose control [3–12], although the JDS guidelines do not state the recommended frequency of HbA1c testing. Hence, we defined ‘≥4 HbA1c testing during the study period’ as an indicator of good performance, based on the ADA recommendation of HbA1c testing every 3 months for unstable patients [1].…”
Section: Methodsmentioning
confidence: 99%
“…Several studies have assessed the quality of diabetes care by using administrative data in the USA [5–11] and other developed countries [3,12] in an effort to improve diabetes care practices. However, although the Japan Diabetes Society (JDS) issued its comprehensive practice guidelines in 2004 [13], to date, very few studies examining the quality of diabetes care have been published [14–16].…”
We found high performance rates for HbA1c testing, while the annual rates for eye examinations and nephropathy screenings were suboptimal. Using administrative data would facilitate more comprehensive assessment of the quality of care in Japan.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.